De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.

Hacohen Y, Androdias G, Arrambide G, Bruijstens AL, Ciccarelli O, Cobo-Calvo A, Flanagan EP, Kim HJ, Iacobaeus E, Lünemann JD, Stankoff B, Tintore M, Marignier R.